Skip to main content
PMC home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1990 Jul;10:30–33.

99mTc radioimmunoscintigraphy of colorectal cancer.

M Granowska 1, S J Mather 1, K E Britton 1, S Bentley 1, P Richman 1, R K Phillips 1, J M Northover 1
PMCID: PMC2149513  PMID: 2166551

Abstract

The monoclonal antibody PR1A3 against a normal colonic columnar cell surface antigen has been labelled with 99mTc and used for imaging colorectal cancer. High uptake in undifferentiated cancer is seen. The tumour to mucosa ratio was up to 63:1 and the percentage of the injected activity in the tumour up to 1.7 X 10(-2%)g-1. As 99mTc is continuously available in a Nuclear Medicine Department, on receipt of a request the study may be completed within 24 h enabling radioimmunoscintigraphy to be used routinely in the management of patients with colorectal cancer.

Full text

PDF
30

Images in this article

31Figure 1
on p.31
32Figure 2
on p.32

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum R. P., Hertel A., Lorenz M., Schwarz A., Encke A., Hör G. 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun. 1989 May;10(5):345–352. doi: 10.1097/00006231-198905000-00005. [DOI] [PubMed] [Google Scholar]
  2. Britton K. E., Granowska M., Nimmon C. C., Crowther M., Mather S., Bomanji J., Shepherd J. Monitoring the in vivo behaviour of immunoglobulins with radiotracers: imaging approaches and data processing techniques. Int J Rad Appl Instrum B. 1989;16(2):105–109. doi: 10.1016/0883-2897(89)90180-3. [DOI] [PubMed] [Google Scholar]
  3. Britton K. E., Granowska M. Radioimmunoscintigraphy in tumour identification. Cancer Surv. 1987;6(2):247–267. [PubMed] [Google Scholar]
  4. Granowska M., Jass J. R., Britton K. E., Northover J. M. A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorectal Dis. 1989;4(2):97–108. doi: 10.1007/BF01646868. [DOI] [PubMed] [Google Scholar]
  5. Hnatowich D. J., Layne W. W., Childs R. L., Lanteigne D., Davis M. A., Griffin T. W., Doherty P. W. Radioactive labeling of antibody: a simple and efficient method. Science. 1983 May 6;220(4597):613–615. doi: 10.1126/science.6836304. [DOI] [PubMed] [Google Scholar]
  6. Mach J. P., Carrel S., Forni M., Ritschard J., Donath A., Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med. 1980 Jul 3;303(1):5–10. doi: 10.1056/NEJM198007033030102. [DOI] [PubMed] [Google Scholar]
  7. Richman P. I., Bodmer W. F. Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization. Int J Cancer. 1987 Mar 15;39(3):317–328. doi: 10.1002/ijc.2910390309. [DOI] [PubMed] [Google Scholar]
  8. Salvatore M., Lastoria S., Del Vecchio S., Mansi L. Detection of colon cancer with radiolabelled monoclonal antibodies. Int J Rad Appl Instrum B. 1989;16(2):103–104. doi: 10.1016/0883-2897(89)90179-7. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES